Aktuella utlysningar, vecka 20, 2019

Publicerat 2019-05-15 14:20. Uppdaterat 2019-05-16 11:39This page in English

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska utlysningar

Medel för forskning inom strålskyddsområdet - Strålsäkerhetsmyndigheten

Syftar till att stödja nationell kompetens inom strålskyddsområdet. Bidrag uppgår till SEK 500,000.

Closing date: 3 June 2019

Medel för forskning inom strålskyddsområdet - Strålsäkerhetsmyndigheten 

Hjärnfondens postdoktorala stipendier - Hjärnfonden

Stödjer forskning rörande hjärnans och övriga nervsystemets sjukdomar, skador och funktionsnedsättningar, men även den friska hjärnan med dess normala funktioner och utveckling.

Closing date: 10 June 2019

Hjärnfondens postdoktorala stipendier - Hjärnfonden 

Biotechnology-based synthesis and production research grants - Novo Nordisk Foundation

Support fundamental and applied research projects generating products in improved and more sustainable ways. Grants are worth up to DKK 4 million for up to three years.

Closing date: 21 June 2019

Biotechnology-based synthesis and production research grants - Novo Nordisk Foundation 

Forskningsanslag - Forska Utan Djurförsök

Stödjer forskning inom alla områden där djurförsök sker idag. Ser gärna ansökningar som kännetecknas av nytänkande för att hitta möjligheter att ersätta eller på andra sätt göra djurförsök onödiga.

Closing date: 27 June 2019

Forskningsanslag - Forska Utan Djurförsök 

Science and SciLifeLab prize for young scientists Science for Life Laboratory

Recognises the best research thesis related to life sciences. A total of four prizes are available. Category prizes are worth USD 10,000 each, and the grand prize is worth USD 30,000. 

Closing date: 15 July 2019

Science and SciLifeLab prize for young scientists Science for Life Laboratory 

Europeiska utlysningar

Clinical trials grants - Anticancer Fund

The Anticancer Fund invites letters of intent for its clinical trials grants. These support clinical trials that aim at reducing recurrence rates for cancer patients treated with curative intent. The focus is on cancer types with high rates of recurrence despite curative-intent treatments, including the most common forms of pancreatic, brain, lung, oesophagus, gastric, liver, gallbladder, ovarian, bladder cancers and sarcomas.

Closing date (Letter of Intent): 16 June 2019

Clinical trials grants - Anticancer Fund

Marie Skłodowska Curie Actions Individual Fellowships 2019

MSCA-IF are postdoc fellowships, for a project within Europe with a 2-year European Fellowship, or outside Europe (2 years) with a mandatory 1-year return phase to Europe with the 3-year Global Fellowship. Applicants are fellows with an identified PI and Host Organisation. The fellows should have a PhD degree or equivalent four years full-time research experience by the time of deadline 2019-09-11. Grants are typically up to €203,852 for two years for incoming fellowships to Sweden and used for salary and allowances for the fellow; research and overhead.

Closing date: 11th September 2019.

The MSCA-IF 2019 Call

Second open call - Activage

Activage invites proposals for its second open call. This supports innovative internet of things enabled solutions for active and healthy ageing within the Activage deployment sites providing IoT based services to their citizens. The proposal must demonstrate the existence of a programme or project of delivery of active ageing services, currently running and serving a senior population and caregivers.

Closing date: 21 June 2019

Second open call - Activage

Second open call - Activage 

General internal medicine research grant - Foundation for the Development of Internal Medicine in Europe

The Foundation for the Development of Internal Medicine in Europe invites applications for its general internal medicine research grant. This promotes exchanges between European researchers enabling them to conduct research dedicated to polymorbidity and other common conditions in internal medicine. The project can cover translational medicine, basic or clinical research.

Closing date: 30 June 2019

General internal medicine research grant - Foundation for the Development of Internal Medicine in Europe

Closing date: Project grants - European Society of Contraception and Reproductive Health

The European Society of Contraception and Reproductive Health invites applications for its project grants. These support an individual, group, institute or organisation with a scientific project related to the aims of the ESC. Examples of eligible projects include research into methods or provision of contraception, sexual and reproductive health, validated questionnaires to understand uptake or utilisation of a method or procedure or a needs assessment within a community or locale.

Closing date: 30 June 2019

Project grants - European Society of Contraception and Reproductive Health

Amerikanska utlysningar

Federal Funding agencies

HIV-1 infection of the Central Nervous System (R01): NIH

This Funding Opportunity Announcement (FOA) invites research grant applications focused on defining and understanding the pathogenic mechanisms involved in Human Immunodeficiency Virus (HIV)-1 induced CNS dysfunction, but within the context of viral suppression and Antiretroviral therapy (ART). The FOA further supports research to identify therapeutic targets against which treatments may be developed to prevent the neurobehavioral and neurological co-morbidities in HIV-1 infected individuals. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. 

Closing date: Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.

Funding Opportunity Announcement (FOA): PA-17-100

HIV-1 infection of the Central Nervous System (R01): NIH 

NIDCR Small Grant Program for New Investigators (R03): NIH

This NIDCR Small Grant Program for New Investigators supports basic and clinical research conducted by scientists who are in the early stages of establishing an independent research career in oral, dental and craniofacial research. This R03 program supports pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data for a subsequent investigator­ initiated Research Project Grant (R01) or equivalent application.

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-16-409

NIDCR Small Grant Program for New Investigators (R03): NIH 

Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional): NIH

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research that examines the relationship between asthma, obesity and self-management.  It seeks to build the science of obesity, asthma, and self-management awareness. Examples of approaches to this opportunity include but are not limited to the following:

  • Test interventions that promote health behaviors for individuals with chronic conditions especially when other family also have chronic conditions and are at risk of exacerbation of their illness.
  • Identify novel technologies or other approaches for individuals, families, and communities to use that promote health behaviors and accessing/imparting/acting on health information and self-management.
  • Determine and test effective methods for dissemination of interventions into practice and methods to sustain these interventions in the community.
  • Develop outcome measures (short and long term) to assess effectiveness of interventions.
  • Examine the use of decision support and personalized self-management interventions for those with existing health disparities and functional disabilities.
  • Develop and test interventions aimed at helping the individuals, caregivers, families, or supportive others to better fill their role while improving their own health and quality of life
  • Identify barriers and facilitators to achieving effective control and maintain health and quality of life to inform future self-management interventions
  • Examine environmental factors, including built environments, diet composition, macro and micronutrient availability, total caloric intake, that may trigger, modulate or play permissive roles in the development of asthma and/or obesity and its role on management
  • Design intervention studies to determine the impact of weight loss to include self-management in obese individuals with asthma
  • Examine the gender differences in the prevalence/ etiology/ predisposing factors/ self- management/ drug efficacy of obesity and asthma
  • Determine the possible associations between an asthma-induced low physical activity life style (low energy expenditure) and predilection for obesity and effects on self-management
  • Examine possible relationships between asthma, sleep disorders, and obesity and self-management behavior

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-18-379

Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional): NIH 

Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional): NIH

The purpose of this funding announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health (NIH) is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.

Specific Areas of Research Interest: Examples of research that are encouraged by this FOA are given below and are not meant to be exclusive:

  • In what states and cities are all overdose deaths routinely tested for both alcohol and drugs, and what are the percentage and types of overdose deaths that involve alcohol?
  • How can testing be increased in other cities/states?
  • Does the percent involving alcohol vary by type of drug either illicit or prescription drugs illicitly used?
  • Do these percentages vary by age, gender, and race/ethnicity?
  • What proportion of overdoses is unintentional, and does this vary by alcohol involvement?
  • How were drugs and alcohol involved in overdoses obtained?
  • What are the trends over time, and have there been greater increases in overdoses from drugs and alcohol in combination rather than drugs alone or alcohol alone?
  • What is the impact of various interventions to reduce overdoses, such as drug package informational inserts, prescription monitoring laws and registries?
  • What impact do various alcohol policies have on alcohol and drug-related overdoses (e.g., legal drinking age changes, changes in alcohol prices/taxes, outlet density, hours of sale, and monopoly versus privatized sales)?
  • What impact does recreational and medical marijuana legalization have on overdoses involving marijuana, other drugs, and alcohol. Has this increased the use of edibles and does that affect rates of overdose from alcohol and marijuana?
  • What impact do various drug driving laws have on drug overdose rates?
  • What is the impact of early age of drug and alcohol initiation on overdoses involving alcohol and drugs?

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-18-863 (R01), PA-18-861 (R03), PA-18-862 (R21)

Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional): NIH

Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional): NIH

Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 - Clinical Trial Optional): NIH

 

Foundation

Established investigator grant, Scleroderma Foundation, US

Purpose: The Scleroderma Foundation seeks applications from promising established investigators both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.

Eligibility Requirements: Applicants must have a doctorate degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences; must have completed a postdoctoral fellowship; and have been principal investigator on grants from the Scleroderma Foundation or other national, private or government agencies in the past.

Closing date: September 16, 2019   

Established investigator grant, Scleroderma Foundation, US 

Translational research program, Leukemia & Lymphoma Society, US

The Leukemia & Lymphoma Society funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application. Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. The application should have a clear plan for the eventual clinical translation of the studies proposed and the results expected. This feature will be an important consideration of the review process.

Closing date: The Translational Research Program will open for new Letters of Intent beginning June 1, 2019. Please check their website for updates!

Translational research program, Leukemia & Lymphoma Society, US 

Länkar